Naksha Market intelligence
All research
CRMSalesforceEnterprise applications

Salesforce at $234.46

Salesforce owns the customer record, but AI is forcing it to prove that a mature software empire can become a growth company again.

Salesforce has already won the first argument.

Customer relationship management moved to the cloud, and Salesforce became the system of record.

The new argument is harder.

Can Agentforce, Data 360, and the acquired Informatica assets make the platform grow faster, or will AI become another feature inside a mature software suite?

At $234.46, the stock does not require a miracle.

It does require durable growth, disciplined acquisitions, and real earnings per share after stock compensation.

What Salesforce actually controls

Salesforce controls customer context.

Sales, service, marketing, commerce, collaboration, analytics, and data-management tools all connect to the same enterprise relationships.

That matters because useful agents need permissioned data and a workflow in which to act.

In fiscal Q2 2027, revenue rose 11% to $11.3 billion. Current remaining performance obligation reached $33.5 billion, up 14% in constant currency.

Subscription and support revenue grew 12%, including the Informatica contribution.

Why does that matter?

Because the installed base is still expanding, and the contractual revenue signal is stronger than the headline growth rate suggests.

Business quality versus stock valuation

Salesforce has recurring revenue, high switching costs, a broad product suite, and an ecosystem of administrators, consultants, and developers.

The company has also become much more profitable.

Q2 GAAP operating margin was 20.5%, non-GAAP operating margin was 34.1%, and free cash flow rose 81% to $1.1 billion.

That is the quality improvement.

The complication is that acquisition and stock-compensation adjustments remain large. Q2 stock-based compensation was $904 million, and acquired-intangible amortization was $522 million.

Why does that matter?

Because non-GAAP profit is useful for judging operations, but shareholders are paid in GAAP shares and cash.

What $234.46 requires

I use fiscal 2032 as the checkpoint and a 9.9% required annual return over five years.

That hurdle starts with the 5.11% 10-year Treasury yield, adds the 4.14% implied U.S. equity risk premium, and uses a 1.15 bottom-up beta for mature enterprise software.

At a 24 times terminal earnings multiple, today's price requires roughly $15.70 of normalized fiscal 2032 EPS.

That hurdle is not heroic.

It does require cRPO growth to translate into per-share earnings rather than being absorbed by acquisitions, debt, or compensation.

Three possible outcomes

Conservative: about $125 today

Salesforce earns $10 per share in fiscal 2032 and receives a 20 times terminal multiple.

Organic growth settles in the high single digits, agents improve retention but not pricing, and acquisition costs continue to consume part of the margin gains.

The company remains important.

The stock remains expensive.

Base case: about $225 today

Salesforce earns $15 per share in fiscal 2032 and receives a 24 times terminal multiple.

cRPO grows at a low-teens rate, Agentforce and Data 360 deepen customer spend, and buybacks more than offset employee issuance.

That outcome roughly approaches the checked price.

Upside case: about $349 today

Salesforce earns $20 per share in fiscal 2032 and receives a 28 times terminal multiple.

This requires agentic workflows to become a major paid product, Informatica to strengthen the data layer, and GAAP margins to keep expanding.

At $234.46, the market is pricing something close to my base case.

Debt, dilution, and acquisition risk

Salesforce's Q2 Form 10-Q showed $33.3 billion of debt after the company issued $24.8 billion in the first half.

Much of that financing accompanied acquisitions and a $25 billion accelerated share repurchase.

Salesforce initially received about 103 million shares under that repurchase at an average price of $198.34.

That can create per-share value.

But buybacks do not erase stock compensation economically. The filing disclosed $8.3 billion of remaining stock-compensation expense from outstanding awards.

The test is simple: does the fully diluted share count fall after every grant, acquisition, and repurchase?

What to watch out for

  • cRPO and organic subscription growth - because acquired revenue should not be mistaken for product acceleration.
  • Agentforce consumption and paid deployments - because demonstrations matter less than recurring customer spend.
  • Data 360 and Informatica integration - because agents need governed enterprise data to become useful.
  • GAAP operating margin and free cash flow - because the margin story should survive stock compensation and acquisition costs.
  • Net debt and acquisition spending - because another large deal could reset the capital-allocation story.
  • Fully diluted shares - because the $25 billion buyback matters only if ownership per share actually rises.

What could change the thesis

The thesis would strengthen if organic cRPO accelerates, Agentforce becomes a measurable paid engine, and GAAP earnings per share grow while debt falls.

The thesis would weaken if reported growth depends on acquisitions, AI products fail to change customer spend, or buybacks merely offset ongoing dilution.

The disconfirming evidence would be a larger platform without faster owner earnings per share.

Bottom line

Salesforce owns one of the most valuable enterprise data and workflow positions in software.

Business quality: high.

Growth: improving, but partly acquired.

Capital allocation: more complicated than the buyback headline suggests.

Valuation: close to my base case.

At $234.46, Salesforce can work if its AI products make the installed base more valuable without another expensive reinvention.

The practical principle: when software growth is mixed with acquisitions and stock compensation, follow organic contract growth and diluted earnings per share, not the adjusted headline.

Sources

Scenario values are analytical estimates, not company guidance or price targets. Educational only - not financial advice.

Continue the library

Compare the assumption, not just the ticker.

Browse all valuation research